Pneumococcal Vaccine Response for Spleen Injury Patients
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
Recruiting
Phase 2
Interventional Study
Asplenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 75 (estimated)
- Sponsor
- University of California, Davis · Other
Who this trial is looking for
This trial is looking for adult trauma patients who have injured their spleen. Participants will help researchers understand how well the pneumococcal vaccine works for protecting against infections.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult trauma patient aged 18 to 65 years old.
- I have sustained an injury to my spleen.
You may not be able to join if
- I am younger than 18 years old.
- I am older than 65 years old.
- I was initially planned for nonoperative management but later had embolization or splenectomy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Persons without a spleen are susceptible to potentially lethal infections from certain bacteria, with pneumococcus being the most prevalent. Vaccines are provided to help protect against these infections, though they do not so with certainty. Trauma patients who sustain an injury to their spleen currently have three treatment options available for the treating surgeon - nonoperative management, em…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult trauma patients (aged 18 to 65 years old) sustaining a splenic injury.
Exclusion Criteria:
* Ages less than 18 and greater than 65
* Initial planned nonoperative management patient who subsequently undergoes embolization or splenectomy will be withdrawn from the study.
Contacts